Rapamycin vs Methotrexate in Diffuse SSc

Clinical trial NCT00241189 · COMPLETED

Trial details

NCT number: NCT00241189
Sponsor: University of California, Los Angeles
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 2002-08-01
Primary completion: 2006-06-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.